Cosmetics, namely make up foundation, hair shampoo, lipstick, eye shadow and solid powder for compacts; cosmetic preparations for skin care, namely skin lotions; dentifrices, namely tooth pastes and tooth gels; cosmetics for pet, namely shampoo for pets.

Unlike conventional methods of polyunsaturated fatty acids (PUFA) extraction that utilize solvents, enzymes, urea complexation and molecular distillation, the Bio-Extraction Process (BEP) utilizes supercritical fluid extraction (SFE) using carbon dioxide (CO2) to produce cleaner (residue free), higher quality PUFA and astaxanthin extracts. Additional advantages of SFE, using CO2, include its tasteless, odourless, non-toxic, non-flammable and generally regarded as safe (GRAS) properties. These additional advantages are crucial as other suppliers of omega-3 have made great strides in removing the fishy taste and smell from these oils, often accomplished through deodorization or encapsulation technologies. Furthermore, the oils used to provide omega-3 fortification in foods and beverages must be fresher and with less oxidative waste because oxidation affects the smell and taste of the food, thus the advantages of the BEP address these key market demands.

Unlike conventional methods of polyunsaturated fatty acids (PUFA) extraction that utilize solvents, enzymes, urea complexation and molecular distillation, the Bio-Extraction Process (BEP) utilizes supercritical fluid extraction (SFE) using carbon dioxide (CO2) to produce cleaner (residue free), higher quality PUFA and astaxanthin extracts. Additional advantages of SFE, using CO2, include its tasteless, odourless, non-toxic, non-flammable and generally regarded as safe (GRAS) properties. These additional advantages are crucial as other suppliers of omega-3 have made great strides in removing the fishy taste and smell from these oils, often accomplished through deodorization or encapsulation technologies. Furthermore, the oils used to provide omega-3 fortification in foods and beverages must be fresher and with less oxidative waste because oxidation affects the smell and taste of the food, thus the advantages of the BEP address these key market demands.

Plastics, unprocessed; synthetic resins, unprocessed; artificial resins, unprocessed.

soaps, namely, body soaps, facial soaps, deodorant soaps, liquid hand and body soaps, perfumed soaps and bar soaps, perfumeries and cosmetics, including, skin care, hair care, body care and make-up products, namely: non-medicated skin care preparations; hair care preparations; body care preparations, namely body soaps, body creams, body lotions, body powders, non-medicated deodorants and anti-perspirants, sunscreen, sun block and sun tanning preparations, preparations to protect the skin from sun, bath beads, bath foam, bath gels, bath lotion, bath oil, bath powder, and non-medicated bath salts; make-up preparations and make-up, namely eye makeup and facial makeup, nail polish, nail lacquer, nail base coat, nail top coat.

Packaging containers comprised of paperboard for food and beverages.

Bubble gel and fine cotton eye anti-aging mask and moisturizer, exfoliating mousse, anti-aging eye mask, anti-acne mask and cream, collagen mask, massage powder, aromatic body and skin revitalizing oil and solution.

Pharmaceutical preparations and substances for the treatment of diseases in the field of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory diseases of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, fungal infection; chemical preparations for pharmaceutical purposes, namely vesicles for in vivo use; diagnostic preparations and substances, all for in vivo use for use in the fields of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory diseases of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, fungal infection; micro-organisms and preparation of micro-organisms for physically absorbing and removing chemicals causing pains and inflammation, all for medical and veterinary use; infants foods; nutritional supplements for humans and animals general health and wellbeing; vitamins, minerals and mineral salts; medicated confectionery for the treatment of inflammation and respiratory ailments; enzyme preparations for the treatment of haemophilia; pharmaceuticals in the field of oncology, cardiovascular disease, respiratory disease, and gastrointestinal diseases; anti-inflammatories; anti-infectives; preparations for the treatment of the central nervous system, namely central nervous system infections and central nervous system diseases; diagnostic preparations for medical and topical use in the fields of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, fungal infection; topical and parenteral preparations of vesicles, being molecules, namely phospholipids for the treatment of inflammation; chemical preparations in the form of vesicles for medical and veterinary purposes for the treatment of inflammation and pain, using phospholipids; chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation, for the treatment of haemophilia; preparations of arachidonic acids; dispersions and dry preparations of liposomal active substance carriers for pharmaceutical, cosmetic and veterinary substances; cosmeceutical preparations for medical use for the treatment of pain and inflammation of the upper dermal layers; local anaesthetics; steroids; anti-inflammatory drugs; pharmaceuticals for the treatment of nail fungal infections; human vaccines and veterinary vaccines and human immunotherapeutic vaccines and veterinary immunotherapeutic vaccines; surgical apparatus for the diagnosis and treatment of diseases in the field of oncology, cardiovascular disease and central nervous system diseases, medical apparatus, namely topically applied gel containing nanostructures for the treatment of pain and inflammation; artificial limbs, eyes and teeth; apparatus for carrying out diagnostic tests for medical purposes in the fields of oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal disease, and central nervous systems diseases, namely monitors, scanners, ultrasound equipment for carrying out diagnostic tests for medical purposes in the field of oncology, cardiovascular disease, respiratory disease, gastro-intestinal diseases, osteoarthritis, rheumatism, inflammatory diseases, namely inflammatory joint diseases, inflammatory skin diseases, inflammatory diseases affecting articulating cartilage, connective tissues, tendons and ligaments, inflammatory of muscle tissues, inflammatory diseases of the eyes, inflammatory diseases of the middle and inner ear, inflammatory diseases of the nasal and paranasal passages and sinuses, single gene disorders, bone and blood diseases, reproductive system disorders, asthma, atopic eczema, psoriasis, bronchospasm, venous thrombotic disorders, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout or macular degeneration, fungal infection; syringes; injectors; medical thermometers; blood sugar meters; fibrin scaffolds; stents; x-ray machines.

Mattresses and bedding products, namely bed blankets, duvets, duvet covers, bed pads, bed linen, dust ruffles, bed skirts, pillows, pillow cases, pillow shams and comforters.

A solution for the administration as an aid in the treatment of non-infectious diarrhea in horses, cattle, dogs and cats.